Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

NCT05255991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

597

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease

Interventions

DRUG: Placebo
DRUG: Inhaled Treprostinil
DEVICE: Treprostinil Ultrasonic Nebulizer

Sponsor

United Therapeutics